MB and rhabdomyolysis: An increasing number of studies suggest the effectiveness of hemoadsorption (HA) in managing severe rhabdomyolysis.1,2 An effective reduction in myoglobin levels through HA has been reported, compared to standard hemodialysis with high-flux membranes and high cutoff membranes.1,2 Myoglobin is the main target of extracorporeal blood purification therapies due to its molecular weight of 17 kDa, which allows it to be effectively removed by HA.